The latest semaglutide (Ozempic; Novo Nordisk) approval is set to tackle a major need for patients with both type 2 diabetes ...
News Medical on MSN8d
Why do people with obesity, but without diabetes, start taking semaglutide?Research identifies key factors affecting semaglutide initiation among obese individuals without diabetes, revealing ...
Semaglutide exposure was significantly associated with a higher incidence rate and independently predicted a higher risk for upcoming nonarteritic anterior ischemic optic neuropathy. HealthDay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback